The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions

Pseudoarthrosis—the failure of normal fracture healing—remains a significant orthopedic challenge affecting approximately 10–15% of long bone fractures, and is associated with significant pain, prolonged disability, and repeated surgical interventions. Despite extensive research into the pathophysio...

Full description

Saved in:
Bibliographic Details
Main Authors: Amalia Kotsifaki, Georgia Kalouda, Sousanna Maroulaki, Athanasios Foukas, Athanasios Armakolas
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Diseases
Subjects:
Online Access:https://www.mdpi.com/2079-9721/13/3/75
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850205379079700480
author Amalia Kotsifaki
Georgia Kalouda
Sousanna Maroulaki
Athanasios Foukas
Athanasios Armakolas
author_facet Amalia Kotsifaki
Georgia Kalouda
Sousanna Maroulaki
Athanasios Foukas
Athanasios Armakolas
author_sort Amalia Kotsifaki
collection DOAJ
description Pseudoarthrosis—the failure of normal fracture healing—remains a significant orthopedic challenge affecting approximately 10–15% of long bone fractures, and is associated with significant pain, prolonged disability, and repeated surgical interventions. Despite extensive research into the pathophysiological mechanisms of bone healing, diagnostic approaches remain reliant on clinical findings and radiographic evaluations, with little innovation in tools to predict or diagnose non-union. The present review evaluates the current understanding of the genetic and biological basis of pseudoarthrosis and highlights future research directions. Recent studies have highlighted the potential of specific molecules and genetic markers to serve as predictors of unsuccessful fracture healing. Alterations in mesenchymal stromal cell (MSC) function, including diminished osteogenic potential and increased cellular senescence, are central to pseudoarthrosis pathogenesis. Molecular analyses reveal suppressed bone morphogenetic protein (BMP) signaling and elevated levels of its inhibitors, such as Noggin and Gremlin, which impair bone regeneration. Genetic studies have uncovered polymorphisms in BMP, matrix metalloproteinase (MMP), and Wnt signaling pathways, suggesting a genetic predisposition to non-union. Additionally, the biological differences between atrophic and hypertrophic pseudoarthrosis, including variations in vascularity and inflammatory responses, emphasize the need for targeted approaches to management. Emerging biomarkers, such as circulating microRNAs (miRNAs), cytokine profiles, blood-derived MSCs, and other markers (B7-1 and PlGF-1), have the potential to contribute to early detection of at-risk patients and personalized therapeutic approaches. Advancing our understanding of the genetic and biological underpinnings of pseudoarthrosis is essential for the development of innovative diagnostic tools and therapeutic strategies.
format Article
id doaj-art-748db5a75abe4453a3c47a5bf3d83cbd
institution OA Journals
issn 2079-9721
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj-art-748db5a75abe4453a3c47a5bf3d83cbd2025-08-20T02:11:05ZengMDPI AGDiseases2079-97212025-03-011337510.3390/diseases13030075The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future DirectionsAmalia Kotsifaki0Georgia Kalouda1Sousanna Maroulaki2Athanasios Foukas3Athanasios Armakolas4Physiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, GreecePhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, GreecePhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, GreeceThird Department of Orthopaedic Surgery, “KAT” General Hospital of Athens, 2, Nikis Street, 14561 Kifissia, GreecePhysiology Laboratory, Medical School, National and Kapodistrian University of Athens, 11527 Athens, GreecePseudoarthrosis—the failure of normal fracture healing—remains a significant orthopedic challenge affecting approximately 10–15% of long bone fractures, and is associated with significant pain, prolonged disability, and repeated surgical interventions. Despite extensive research into the pathophysiological mechanisms of bone healing, diagnostic approaches remain reliant on clinical findings and radiographic evaluations, with little innovation in tools to predict or diagnose non-union. The present review evaluates the current understanding of the genetic and biological basis of pseudoarthrosis and highlights future research directions. Recent studies have highlighted the potential of specific molecules and genetic markers to serve as predictors of unsuccessful fracture healing. Alterations in mesenchymal stromal cell (MSC) function, including diminished osteogenic potential and increased cellular senescence, are central to pseudoarthrosis pathogenesis. Molecular analyses reveal suppressed bone morphogenetic protein (BMP) signaling and elevated levels of its inhibitors, such as Noggin and Gremlin, which impair bone regeneration. Genetic studies have uncovered polymorphisms in BMP, matrix metalloproteinase (MMP), and Wnt signaling pathways, suggesting a genetic predisposition to non-union. Additionally, the biological differences between atrophic and hypertrophic pseudoarthrosis, including variations in vascularity and inflammatory responses, emphasize the need for targeted approaches to management. Emerging biomarkers, such as circulating microRNAs (miRNAs), cytokine profiles, blood-derived MSCs, and other markers (B7-1 and PlGF-1), have the potential to contribute to early detection of at-risk patients and personalized therapeutic approaches. Advancing our understanding of the genetic and biological underpinnings of pseudoarthrosis is essential for the development of innovative diagnostic tools and therapeutic strategies.https://www.mdpi.com/2079-9721/13/3/75pseudoarthrosisnon-union fracturesgenetic biomarkersbone healingbiological biomarkersmesenchymal stromal cells
spellingShingle Amalia Kotsifaki
Georgia Kalouda
Sousanna Maroulaki
Athanasios Foukas
Athanasios Armakolas
The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
Diseases
pseudoarthrosis
non-union fractures
genetic biomarkers
bone healing
biological biomarkers
mesenchymal stromal cells
title The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
title_full The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
title_fullStr The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
title_full_unstemmed The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
title_short The Genetic and Biological Basis of Pseudoarthrosis in Fractures: Current Understanding and Future Directions
title_sort genetic and biological basis of pseudoarthrosis in fractures current understanding and future directions
topic pseudoarthrosis
non-union fractures
genetic biomarkers
bone healing
biological biomarkers
mesenchymal stromal cells
url https://www.mdpi.com/2079-9721/13/3/75
work_keys_str_mv AT amaliakotsifaki thegeneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT georgiakalouda thegeneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT sousannamaroulaki thegeneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT athanasiosfoukas thegeneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT athanasiosarmakolas thegeneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT amaliakotsifaki geneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT georgiakalouda geneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT sousannamaroulaki geneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT athanasiosfoukas geneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections
AT athanasiosarmakolas geneticandbiologicalbasisofpseudoarthrosisinfracturescurrentunderstandingandfuturedirections